Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial

スポンサーリンク

概要

• 論文の詳細を見る
• 2013-02-01

著者

• Hatake Kiyohiko

  Cancer Chemotherapy Center The Cancer Institute Hospital Of Japanese Foundation For Cancer Research

• SHIRAO Kuniaki

  Oita University

• OHTSU Atsushi

  National Cancer Center Hospital East

• HAMAGUCHI Tetsuya

  National Cancer Center

• DOI Toshihiko

  National Cancer Center Hospital East

• CHIN Kensho

  Cancer Institute Hospital of Japanese Foundation for Cancer Research

• NOGUCHI Kazuo

  MSD K. K.

• OTSUKI Tetsuya

  MSD K. K.

• MEHTA Anish

  Merck Sharpe & Dohme Corp

関連論文

• Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
• PJ-157 Bone Marrow-Derived CXCR4^+ Cells Mobilized by M-CSF Participate in the Prevention of Cardiac Dysfunction after Myocardial Infarction in Mice(Acute myocardial infarction, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Socie
• FRS-051 Critical Role of Bone Marrow-derived CXCR4^+ Cells Mobilized by M-CSF in Neointimal Formation After Vascular Injury in Mice(Vascular Injury and Neointimal Formation in Animal Models (basic), The 71st Annual Scientific Meeting of the Japanese Circu
• Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
• Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
• Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial

スポンサーリンク